Table 4 Changes between baseline and follow up for the clinical endpoints

Weight, Kg

− 7.8 (19.7)

0.4 (4.1)

0.014^a

Abdominal circumference, cm

− 3 (− 9.0 to − 1.0)

− 0.9 (− 6.0 to 5.0)

0.249^b

HbA1c, mmol/mol

− 11.4 (10.0)

− 4.7 (11.1)

0.001^a

Hemoglobin, g/L

− 3.0 (− 9.0 to 3.0)

1.0 (− 8.2 to 5.5)

0.363^b

Creatinine, mg/dl

0.04 (0.15)

0.03 (0.17)

0.946^a

eGFR, ml/min/1,73m2

− 3.0 (13.1)

− 1.8 (10.3)

0.772^a

Cholesterol, mmol/L

− 1.04 (0.9)

− 0.3 (0.9)

0.144^a

LDL cholesterol, mmol/L

− 0.7 (− 1.6 to 0.2)

− 0.5 (− 0.8 to 0.1)

0.261^b

HDL cholesterol, mmol/L

− 0.5 (− 0.3 to 0.1)

0.1 (0.1 to 0.2)

0.117^b

Triglycerides, mmol/L

− 0.3 (− 1.1 to 0.1)

− 0.1 (− 0.7 to 0.7)

0.140^b

Systolic blood pressure, mmHg

− 4.5 (24.6)

2.0 (17.6)

0.441^a

Diastolic blood pressure, mmHg

− 0.8 (18.7)

− 2.3 (12.1)

0.805^a

Heart rate, beats per minute

8.0 (7.7)

− 3.3 (12.5)

0.008^a

Target lesion revascularization, n (%)

0 (0.0)

3 (20.0)

0.224^c